Modern Care Journal

Published by: Kowsar

HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study

Gholamreza Sharifzadeh 1 , Asghar Zarban 2 , Morteza Hajihosseini 3 , Ghodsiyeh Azarkar 4 , Kambiz Mahdizadeh 5 , Majid Shayesteh 6 and Masood Ziaee 4 , *
Authors Information
1 Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Antioxidant and Metabolism Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
4 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
5 Deputy for Health, Birjand University of Medical Sciences, Birjand, Iran
6 Birjand CDC Manager, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Modern Care Journal: July 2016, 13 (3); e10297
  • Published Online: April 29, 2016
  • Article Type: Brief Report
  • Received: January 1, 2016
  • Revised: February 26, 2016
  • Accepted: March 13, 2016
  • DOI: 10.5812/modernc.10297

To Cite: Sharifzadeh G, Zarban A, Hajihosseini M, Azarkar G, Mahdizadeh K, et al. HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study, Mod Care J. 2016 ; 13(3):e10297. doi: 10.5812/modernc.10297.

Abstract
Copyright © 2016, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. WHO. . World health statistics 2010. 2010;
  • 2. WHO. . World health statistics 2015. 2015;
  • 3. Modelling of HIV/AIDS in Iran up to 2014. Journal of AIDS and HIV Research. 2011; 3(12)[DOI]
  • 4. Zali MR, Mehr AJ, Rezaian M, Meamar AR, Vaziri S, Mohraz M. Prevalence of intestinal parasitic pathogens among HIV-positive individuals in Iran. Jpn J Infect Dis. 2004; 57(6): 268-70[PubMed]
  • 5. Noroozi M, Mirzazadeh A, Noroozi A, Mehrabi Y, Hajebi A, Zamani S, et al. Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran. Addict Health. 2015; 7(3-4): 164-73[PubMed]
  • 6. Ghasemzadeh I, Shahri RZ, Namazi SA, Sadeghi P, Shojaeddin S. Review of HIV risk factors in prison inmates in Iran. Life Sci J. 2014; 11(4s): 236-9
  • 7. Makiani MJ, Davoodian P, Abedi F, Hossini M, Zare S, Rahimi S, et al. AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012. Electron Physician. 2014; 6(3): 884-9[DOI][PubMed]
  • 8. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016; 16(9)[DOI][PubMed]
  • 9. Movahedi Z, Mahmoudi S, Pourakbari B, Keshavarz Valian N, Sabouni F, Ramezani A, et al. Epidemiology of children with acquired immune deficiency syndrome (stage 3): A referral hospital-based study in Iran. J Med Virol. 2016; 88(1): 64-8[DOI][PubMed]
  • 10. Nematollahi M, Khalesi N, Moghaddasi H, Askarian M. Second Generation of HIV Surveillance System: A Pattern for Iran. Iran Red Crescent Med J. 2012; 14(5): 309-12[PubMed]
  • 11. Rennie S, Turner AN, Mupenda B, Behets F. Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological, and public health concerns. PLoS Med. 2009; 6(1)[DOI][PubMed]
  • 12. KSC. . Review of hiv prevention and care for injection drug users in islamic republic of Iran. 2005;
  • 13. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005; 19(7): 709-16[PubMed]
  • 14. Solomon SS, Mehta SH, Latimore A, Srikrishnan AK, Celentano DD. The impact of HIV and high-risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV prevention. J Int AIDS Soc. 2010; 13 Suppl 2[DOI][PubMed]
  • 15. Ziaee M, Zarban A, Malekinejad P, Akhbary H. Evaluation of HGV viremia prevalence and its co-infection with HBV, HCV, HIV and HTLV-1 in hemophilic patients of Southern Khorassan, Iran. Hepat Mon. 2007; 7(1): 11-4
  • 16. Ziaee M, Sharifzadeh G, Namaee MH, Fereidouni M. Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors among Prisoners in Southern Khorasan Province, Iran. Iran J Public Health. 2014; 43(2): 229-34[PubMed]
  • 17. Ziaee M, Namaei MH, Azarkar G. The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients. Pak J Med Sci. 2015; 31(5): 1246-9[DOI][PubMed]
  • 18. Doosti-Irani A, Holakouie-Naieni K. Determination the Research Priorities in the Field of HIV/AIDS in Iran: A Systematic Review Article. Iran J Public Health. 2016; 45(9): 1149-58[PubMed]
  • 19. Gokengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/AIDS: trends in the Middle East and North Africa region. Int J Infect Dis. 2016; 44: 66-73[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments